Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The immune system releases certain inflammatory chemicals to fight against microbial infections like dysentery, hepatitis and others  however, when these chemicals start acting against body’s own tissues and organs it leads to a condition known as sepsis. The three stages of sepsis include sepsis, severe sepsis, and the final stage of septic shock. Sepsis has a high mortality and morbidity rate. For instance, according to an article published by the National Center for Biotechnology Information in February 2019, it is estimated that the mortality rate of sepsis is 25–30%. Sepsis caused by bacteria involves cascade of reactions such as lack of oxygen supply to cells, inactivation of immune complexes involved in the clearance of bacteria and bacterial particles which further progresses to multiple organ failure.

Global Sepsis Diagnostics Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020.

For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 180,492,131 cases and 3,916,771 deaths due to coronavirus disease (COVID-19) were reported till June 27, 2021, across the globe.

Impact of COVID-19 on Demand and Supply of Sepsis Diagnostics

The COVID-19 pandemic and lockdown in various countries across the globe have negatively impacted the financial status of businesses across all sectors. The biotechnology sector is one such sector which has been majorly impacted by the pandemic.

However, the demand for sepsis diagnostics is increasing in this COVID-19 pandemic owing to rising number of COVID-19 cases reported. For instance, according to a study published by the Global Sepsis Alliance in April 2020, more than 30% of COVID-19 patients reported sepsis related liver injury and 75% patients were observed to have a depressed immune system in the U.S. The study also revealed that sepsis is one of the most critical cause of death amongst COVID-19 patients as all the patients who succumbed to COVID-19 infection had sepsis and around 70% of non-survivors had septic shock.

Moreover, in November 2020, the Hellenic Institute, a Greek health organization and Sanmina Corporation, a U.S. based electronics manufacturer funded a study to develop a novel optical biosensor (OB) point-of-care (POC) device for detection of severe COVID-19 infection and sepsis. Furthermore, according to an investigational study published by BMC (Biomedcentral) Infectious Diseases Journal in November 2020, at the first phase, the specificity and positive predictive value of this OB diagnostic device was 100% for sepsis diagnosis. At the second phase, the specificity was 87.5% and positive predictive value was 91.7%. The sensitivity of OB point-of-care device was estimated to be 83.3% for diagnosis of severe COVID-19 infection. Such developments are expected to have a positive impact on the growth of the market. Thus, COVID-19 pandemic is expected to drive the growth of the global sepsis diagnostics market over the forecast period.

The global sepsis diagnostics market is estimated to be valued at US$ 702.2 Mn in 2021, and is expected to exhibit a CAGR of 9.6% over the forecast period (2021-2028).

request-sample

Sepsis Diagnostics Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 702.2 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 9.6% 2028 Value Projection: US$ 1,334.0 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Blood Culture Media, Assays & Reagents, Instruments, Software
  • By Method: Automated Diagnostics, Conventional Diagnostics
  • By Pathogen: Bacterial Sepsis (Gram-Negative Bacterial Sepsis, Gram-Positive Bacterial Sepsis), Fungal Sepsis, Others
  • By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry
  • By End User: Hospitals, Pathology & Reference Laboratories, Research Laboratories & Academic Institutes 
Companies covered:

BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation

Growth Drivers:
  • Growing prevalence of infectious diseases
  • Increasing research and development activities by market players
  • Increasing product launches and approvals
Restraints & Challenges:
  • Lack of skilled labor in underdeveloped and developing countries

Figure 1: Global Sepsis Diagnostics Market Share (%) Analysis, By Product Type, 2021

Sepsis Diagnostics  | Coherent Market Insights

The increasing number of product launches and approvals is the major factor which is expected to drive the market growth over th e forecast period.

The rising product launches and approvals is expected to drive the growth of the global sepsis diagnostics market over the forecast period. For instance, in April 2019, Beckman Coulter Inc., a U.S. based biomedical testing solutions provider received the U.S Food and Drug Administration 510k clearance for its product Early Sepsis Indicator for diagnosis of sepsis at earlier stages of the infection.

The rising number of cases of infectious diseases such as pneumonia, cholera, toxic shock syndrome, salmonellosis, COVID-19, and others is expected to drive the growth of the global sepsis diagnostics market over the forecast period. For instance, according to the World Health Organization fact sheet published in February 2021, around 1.3-4.0 million cases of cholera are reported every year worldwide. Moreover, according to a research study published by NCBI (National Center for Biotechnology Information) in November 2020, the prevalence of toxic shock syndrome is estimated to be approximately 0.8 to 3.4 per 100,000 in the U.S.

Furthermore, governments of various countries are taking initiatives for raising funds and creating awareness about sepsis is expected to aid in the growth of the global sepsis diagnostics market over the forecast period. For instance, in 2018, the government of Scotland collaborated with Sepsis Research FEAT (The Fiona Elizabeth Agnew Trust), a charitable trust to initiate a fund raising campaign across the country to raise awareness about sepsis.

Global Sepsis Diagnostics Market – Restraints

However, growth of the global sepsis diagnostics market may be hampered, owing to lack of skilled professionals in developing countries such as Bangladesh, Niger, Kenya and others, as the collection and analysis of clinical sample for diagnosis of sepsis requires laboratory skills and knowledge. For instance, according to an article published in Young Scientist Journal in April 2018, the sub-Saharan Africa faces a critical shortage of healthcare workers due to lack of medical graduates, emigration of healthcare professionals and lack of proper healthcare infrastructure which acts as a restraint for development of public health system in that region. Sub-Saharan Africa region is considered to have the weakest healthcare system in the world. Such limitations are expected to hamper the growth of the global sepsis diagnostics market over the forecast period.

Global Sepsis Diagnostics Market – Regional Analysis

On the basis of region, the global sepsis diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to hold dominant position in the global sepsis diagnostics market over the forecast period, owing to rising number of product launches and approvals. For instance, in April 2019, GenMark Diagnostics, Inc. received the U.S. FDA approval for its new panel assay which is used for detection of gram-negative bacteria causing sepsis. Moreover, in April 2019, Becton, Dickinson and Company, a U.S. based biomedical technology company launched it new product BD BACTEC anaerobic platelet media used for identification of contaminated platelet units and decrease the incidences of sepsis in patients receiving platelet transfusion.

Figure 2: Global Sepsis Diagnostics Market Value (US$ Mn), by Region, 2021

Sepsis Diagnostics  | Coherent Market Insights

Global Sepsis Diagnostics Market – Competitive Landscape

Major players operating in the global sepsis diagnostics market include BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation.

Sepsis is a condition wherein the body’s response to infection trigger an inflammation reaction throughout the body. Immune system releases inflammatory chemicals into the bloodstream to clear out pathogens from the body but instead these chemicals cause cascade of reactions that result in organ damage and may be fatal. Few of the symptoms of sepsis include low blood pressure, mental confusion, fever, increased heart rate, and difficulty in breathing. Sepsis may be caused by infectious agents such as bacteria, virus, and fungi. Several factors that increase the risk of sepsis include old age, diabetes, liver disease, use of antibiotics, and usage of invasive medical devices such as catheters.

Market Dynamics

Market players are conducting clinical trials for developing more efficient diagnostic systems for sepsis, which could contribute to the growth of the market over the forecast period. For instance, in February 2020, Inflammatix, Inc., a U.S. based diagnostics company initiated clinical trial study for their product HostDx Sepsis with 1500 participants which is expected to be completed by November 2021. This clinical study investigates the performance of HostDx Sepsis diagnostic test in the diagnosis and prognosis of patients with suspected sepsis.

Market players are focusing on launch of products, which is expected to strengthen their position in the global sepsis diagnostics market. For instance, in July 2018, Thermo Fisher Scientific Inc., a U.S. based diagnostics solutions provider launched its product B·R·A·H·M·S PCT which is a direct POC (Point of Care) assay for early detection of sepsis.

Market players are involved in expanding their presence globally, by entering into collaboration with other companies in order to enhance distribution, this is expected to drive the growth of the global sepsis diagnostics market. For instance, in May 2020, BARDA (Biomedical Advanced Research and Development Authority) and Beckman Coulter Inc., a U.S. based biomedical testing solutions provider entered into a strategic collaboration for development of a diagnostic algorithm for early detection of sepsis in COVID-19 patients.

Key features of the study:

  • This report provides an in-depth analysis of global sepsis diagnostics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global Sepsis Diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global sepsis diagnostics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sepsis diagnostics market

Detailed Segmentation:

  • Global Sepsis Diagnostics Market, By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • Global Sepsis Diagnostics Market, By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • Global Sepsis Diagnostics Market, By Pathogen:
    • Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • Global Sepsis Diagnostics Market, By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Global Sepsis Diagnostics Market, By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • Global Sepsis Diagnostics Market, By Region:
    • North America
      • By Product Type:
        • Blood Culture Media
        • Assays & Reagents
        • Instruments
        • Software
      • By Method:
        • Automated Diagnostics
        • Conventional Diagnostics
      • By Pathogen:
        • Bacterial Sepsis
        • Gram-Negative Bacterial Sepsis
        • Gram-Positive Bacterial Sepsis
        • Fungal Sepsis
        • Others
      • By Technology:
        • Microbiology
        • Molecular Diagnostics
        • Immunoassays
        • Flow Cytometry
      • By End User:
        • Hospitals
        • Pathology & Reference Laboratories
        • Research Laboratories & Academic Institutes
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Blood Culture Media
        • Assays & Reagents
        • Instruments
        • Software
      • By Method:
        • Automated Diagnostics
        • Conventional Diagnostics
      • By Pathogen:
        • Bacterial Sepsis
        • Gram-Negative Bacterial Sepsis
        • Gram-Positive Bacterial Sepsis
        • Fungal Sepsis
        • Others
      • By Technology:
        • Microbiology
        • Molecular Diagnostics
        • Immunoassays
        • Flow Cytometry
      • By End User:
        • Hospitals
        • Pathology & Reference Laboratories
        • Research Laboratories & Academic Institutes
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Blood Culture Media
        • Assays & Reagents
        • Instruments
        • Software
      • By Method:
        • Automated Diagnostics
        • Conventional Diagnostics
      • By Pathogen:
        • Bacterial Sepsis
        • Gram-Negative Bacterial Sepsis
        • Gram-Positive Bacterial Sepsis
        • Fungal Sepsis
        • Others
      • By Technology:
        • Microbiology
        • Molecular Diagnostics
        • Immunoassays
        • Flow Cytometry
      • By End User:
        • Hospitals
        • Pathology & Reference Laboratories
        • Research Laboratories & Academic Institutes
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Blood Culture Media
        • Assays & Reagents
        • Instruments
        • Software
      • By Method:
        • Automated Diagnostics
        • Conventional Diagnostics
      • By Pathogen:
        • Bacterial Sepsis
        • Gram-Negative Bacterial Sepsis
        • Gram-Positive Bacterial Sepsis
        • Fungal Sepsis
        • Others
      • By Technology:
        • Microbiology
        • Molecular Diagnostics
        • Immunoassays
        • Flow Cytometry
      • By End User:
        • Hospitals
        • Pathology & Reference Laboratories
        • Research Laboratories & Academic Institutes
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Blood Culture Media
        • Assays & Reagents
        • Instruments
        • Software
      • By Method:
        • Automated Diagnostics
        • Conventional Diagnostics
      • By Pathogen:
        • Bacterial Sepsis
        • Gram-Negative Bacterial Sepsis
        • Gram-Positive Bacterial Sepsis
        • Fungal Sepsis
        • Others
      • By Technology:
        • Microbiology
        • Molecular Diagnostics
        • Immunoassays
        • Flow Cytometry
      • By End User:
        • Hospitals
        • Pathology & Reference Laboratories
        • Research Laboratories & Academic Institutes
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Blood Culture Media
        • Assays & Reagents
        • Instruments
        • Software
      • By Method:
        • Automated Diagnostics
        • Conventional Diagnostics
      • By Pathogen:
        • Bacterial Sepsis
        • Gram-Negative Bacterial Sepsis
        • Gram-Positive Bacterial Sepsis
        • Fungal Sepsis
        • Others
      • By Technology:
        • Microbiology
        • Molecular Diagnostics
        • Immunoassays
        • Flow Cytometry
      • By End User:
        • Hospitals
        • Pathology & Reference Laboratories
        • Research Laboratories & Academic Institutes
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • BioMérieux SA*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Thermo Fisher Scientific
    • Abbott Laboratories
    • Roche Diagnostics AG
    • Luminex Corporation
    • CytoSorbents Corporation
    • Becton Dickinson Company
    • Danaher Corporation
    • Axis-Shield Diagnostics
    • T2 Biosystems
    • EKF Diagnostics
    • Immunexpress Inc.
    • Response Biomedical Corporation
    • Bruker Corporation

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Method
      • Market Snippet, By Pathogen
      • Market Snippet, By Technology
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Algorithm for Clinical Approach to Sepsis
    • Associated/Predisposing Factors for and Typical Clinical Signs Of Sepsis
    • PEST Analysis
    • Industry Trends
    • Pipeline Analysis
    • Key Highlights
    • Epidemiology
    • Drugs Pricing List
    • Reimbursement Scenario of Sepsis Diagnostics
    • Regulatory Scenario
    • Global Supply Chain Analysis
  4.  Global Sepsis Diagnostics Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact of COVID-19 on Demand and Supply of Sepsis Diagnostics
    • Impact of Covid-19 on the Sepsis Diagnostics Market
  5. Global Sepsis Diagnostics Market, By Product Type, 2017-2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Blood Culture Media
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Assays & Reagents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Software
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  6. Global Sepsis Diagnostics Market, By Method, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Automated Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Conventional Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  7. Global Sepsis Diagnostics Market, By Pathogen, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Bacterial Sepsis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  8. Global Sepsis Diagnostics Market, By Technology, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Microbiology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Molecular Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Immunoassays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Flow Cytometry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  9. Global Sepsis Diagnostics Market, By End User, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Pathology & Reference Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Research Laboratories & Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  10. Global Sepsis Diagnostics Market, By Region, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  11. Competitive Landscape
    • Company Profiles
      • BioMérieux SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Roche Diagnostics AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Luminex Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • CytoSorbents Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Becton Dickinson Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Axis-Shield Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • T2 Biosystems
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • EKF Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Immunexpress Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Response Biomedical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Bruker Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
    • Analyst Views
  12. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 26 figures on "Sepsis Diagnostics Market” - Global Forecast to 2028.

FAQgrowicon

Frequently Asked Questions

The market is expected to exhibit a CAGR of 9.6% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 702.2 Mn in 2021.
BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation are some of the prominent players operating in the market.
The market is expected to be valued at US$ 1,334.0 Mn in 2028.
North America is the prominent region in the market.
Increasing number product launches, rising cases of sepsis, increasing research and development activities by the market players, and increasing strategic collaborations among the market players are some of the driving factors, which are expected to drive growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.